Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
Primary Purpose
Hodgkin's Disease, Lymphoma, Non-Hodgkin
Status
Completed
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
BodyFIX
Sponsored by
About this trial
This is an interventional treatment trial for Hodgkin's Disease
Eligibility Criteria
Inclusion Criteria: All patients undergoing curative or palliative treatment in whom it is considered that immobilization of part or all of an anatomical region would be of benefit to their care. Exclusion Criteria: Any case where ideal treatment may be compromised with use of immobilization method. If the patient has any social issues, language barriers resulting in difficulties comprehending the nature of the study, or poor performance status, that could compromise compliance with the study guidelines.
Sites / Locations
- University Health Network
Outcomes
Primary Outcome Measures
The primary outcome for the study is the average deviation in set-up.
Secondary Outcome Measures
Full Information
NCT ID
NCT00232440
First Posted
October 3, 2005
Last Updated
August 10, 2010
Sponsor
University Health Network, Toronto
Collaborators
Princess Margaret Hospital, Canada
1. Study Identification
Unique Protocol Identification Number
NCT00232440
Brief Title
Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
Official Title
A Study to Examine the Reproducibility of an Immobilization Device (BodyFIX ) to Deliver High Precision Radiation Therapy for Patients With Hodgkin's Disease or Non-Hodgkin's Lymphoma
Study Type
Interventional
2. Study Status
Record Verification Date
August 2010
Overall Recruitment Status
Completed
Study Start Date
January 2003 (undefined)
Primary Completion Date
June 2009 (Actual)
Study Completion Date
June 2009 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
University Health Network, Toronto
Collaborators
Princess Margaret Hospital, Canada
4. Oversight
5. Study Description
Brief Summary
Radiation therapy has a well-established role in the treatment of Hodgkin's Disease and non-Hodgkin's Lymphoma. With technological developments, 3-D Dimensional (3D) planning has evolved as a highly precise treatment planning option. High-precision radiation therapy has the potential for more accurate dose delivery to the tumour volume and can result in a greater sparing of normal tissue. An important component of safe radiotherapy delivery is the feasibility and reproducibility of current and new immobilization devices for highly conformal treatment.
The purpose of this study is to determine the reproducibility of an immobilization device known as BodyFIX(TM) using conventional treatment techniques.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hodgkin's Disease, Lymphoma, Non-Hodgkin
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1, Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
20 (false)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
BodyFIX
Primary Outcome Measure Information:
Title
The primary outcome for the study is the average deviation in set-up.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
All patients undergoing curative or palliative treatment in whom it is considered that immobilization of part or all of an anatomical region would be of benefit to their care.
Exclusion Criteria:
Any case where ideal treatment may be compromised with use of immobilization method.
If the patient has any social issues, language barriers resulting in difficulties comprehending the nature of the study, or poor performance status, that could compromise compliance with the study guidelines.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alex Sun, MD
Organizational Affiliation
Princess Margaret Hospital, Canada
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Health Network
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 2M9
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/Lymphoma
We'll reach out to this number within 24 hrs